Christopher Hite
Director; EVP & Vice Chairman · 2 filings · Latest: May 6, 2026
Kailera Therapeutics, Inc.
Royalty Pharma plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
RPRX | Christopher Hite | EVP & Vice Chairman | May 6, 2026 | Grant/Award | $0.00 | 24,263 | — | 709,399 |